Abstract
Gingival overgrowth was a side effect of several different drug classes, including anticonvulsants, immunosuppressants, and calcium channel blockers. Extracellular collagenous matrix components accumulate together with varying degrees of inflammation to describe it. The anti-epileptic phenytoin is one of the main medications linked to gingival overgrowth. It affects gingival tissues by changing the metabolism of extracellular matrix. This paper aims to present a case report on non-surgical management of phenytoin drug induced gingival enlargement.
Reference13 articles.
1. Desai P, Silver JG. Drug-induced gingival enlargements. Journal of the Canadian Dental Association. 1998;64(4):263–268.
2. Brunet L, Miranda J, Farre M, et al. Gingival enlargement induced by drugs. Drug Safety. 1996; 15(3):219–231. https://doi.org/10.2165/00002018-199615030-00007
3. Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. JAMA. 1939;112(13):1244–1245. https://doi.org/10.1001/jama.1939.02800130028009
4. Faurbye A. Behandling af epilepsi med diphenylhydantoin. Ugeskr Laeg. 1939;101:1350–1354.
5. Strean LR, Leoni E. Dilantin gingival hyperplasia. Newer concepts related to etiology and treatment. NY St Dent J 1959;25:339–347.